Hematopoietic Management in Oncology Practice
December 01, 2003
This timely and elegant articleby Glaspy reviews current datasupporting the clinical role ofhematopoietic growth factors. As theauthor thoroughly discusses, the introductionof myeloid and erythroidregulatory proteins more than a decadeago has had a dramatic impacton the care of patients with a varietyof cancers and hematologic disorders,as well as other diseases. A large bodyof research allows us to draw someimportant conclusions about the rationaland appropriate use of theseagents. However, as stated in thisarticle, a number of important questionsremain.